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Introduction
In cancer chemotherapy, multidrug resistance is the 
main clinical challenge for the active treatment (Szabo 
and Molnar, 1997). Tumor cells develop resistance to 
anti-cancer agent through different mechanism. Among 
these, overexpression of ATP-binding cassette (ABC) 
proteins is also important. The ABC transporters are 
transmembrane proteins which bind to ATP and use the 
energy for the transport of various molecules across cell 
membranes (Gottesman and Ambudkar, 2001; Leonard 
et al., 2003). ABC efflux transporters force out a wide 
range of amphiphilic compounds against the concentration 
gradient. ABC transporters have performed different 
physiological functions, normal tissue protection in the 
liver, kidney and brain. (Gottesman et al., 2002; Sarkadi 
et al., 2006; Szakacs et al., 2006).
P-glycoprotein (P-gp, ABCB1) was the first identified 
drug efflux protein coded by the ABCB1 gene. ABCB1 
consists of 1280 amino acids (170 kDa), which organized in 
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Abstract
 A new compound namely (13-(3,3-dihydroxypropyl)-1,6-dihydroxy-3,4-dihydro-1H-isochromen-8(5H)-one 
(1) was isolated from an ethyl acetate extract of the borne fungi Screlotium rolfsii. Its chemical structure was 
elucidated by spectroscopic analysis. Screlotiumol 1 were evaluated for their effects on the reversion of multidrug 
resistant (MDR) mediated by P-glycoprotein (P-gp) of the soil borne fungi. The multidrug resistant P-glycoprotein 
is a target for chemotherapeutic drugs in cancer cells. In the present study rhodamine-123 exclusion screening 
test on human mdr1 gene transfected mouse gene transfected L5178 and L5178Y mouse T-cell lymphoma 
which showed excellent MDR reversing effect in a dose dependent manner against mouse T-lymphoma cell line. 
Moreover, molecular docking studies of compound-1 also showed better results as compared with the standard. 
Therefore the preliminary results obtained from this study suggest that screlotiumol 1 could be used as a potential 
agent for the treatment of cancer.  
Keywords: Soil borne fungi - Screlotium rolfsii - screlotiumol 1 - MDR - molecular docking.
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two transmembrane domains (Szakacs et al., 2006). ABCB1 
protein is overexpressed in several type human cancer, can 
extrude wide range of drugs (anticancer, antidepressants, 
antihistamines, antibiotics, antiarrhythmics, HIV protease 
inhibitors, immunosuppressants, steroids). Different 
drugs suppress the action of ABCB1 such as valspodar, 
tariquidar, dexniguldipine, and tamoxifen (Germann et 
al., 1993; Lopez and Martinez-Luis, 2014). 
Secondly, the multidrug-resistant protein 1 (MRP1, 
ABCC1) was evaluated in 1992. MRP1 is an efflux 
pump initially discovered in doxorubicin resistant 
lung carcinoma cells, which can display a multi-drug 
resistant phenotype without ABCB1 expression (Cole 
et al., 1992). MRP1 is overexpressed in the blood-brain 
barrier, intestines and oral mucosa (He et al., 2011). 
MRP1 expression is higher in the lung than in any other 
organ and may have protective roles against air pollution 
and inhaled toxins (Sakamoto et al., 2013). MRP1 shows 
poor response to cisplatin therapy with vinorelbine, 
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gemcitabine and paclitaxel (Li et al., 2008). 
Thirdly, the breast cancer resistance protein (BCRP) 
is a homodimer, 72 kDa half-transporter member of the 
ABCG subfamily (ABCG2). Overexpression of BCRP 
is associated with resistance to a broad range of different 
anticancer agents including mitoxantrone, anthracyclines, 
camptothecins, antifolates and flavopiridol (Assaraf, 2006; 
Bihorel et al., 2007; Robey et al., 2007). 
P-gp belongs to the ABC superfamily of transporters 
and also plays a role in the MDR of bacteria and yeast 
against antimicrobials agents. P-gp is considered the best 
known of the ABC proteins, due to its involvement in the 
treatment of cancer and other fatal human diseases(Jones 
and George, 2004). It consists of 1280 amino acids, 
arranged in a single chain with two homologous halves 
having 43% amino acid similarity. Each half has six 
transmembrane domains (TM) and a hydrophilic domain 
containing an ATP-binding site, known as nucleotide 
binding domain (NBD) (Jara et al., 2013).
The fungi kingdom is one of the most important 
kingdoms of microorganism in the biosphere (Turner, 
2000). Microbial activity is the general term used to 
indicate the vast range of activities carried out by soil 
microorganisms. Fungi performing a wide range of 
function in soil by secreting low molecular weight 
compound known as secondary metabolites. Secondary 
metabolites are not essential to the common metabolic 
pathways of the fungi and are often only produced when 
these fungi are stressed condition. Nature has evolved 
to produce a wide range of secondary metabolites. A 
wide range of pharmaceutically significant compounds 
belonging to all structural classes were found to be 
produced by fungi. Until now, approximately 50,000 
microbial metabolites have been discovered. S. rolfsii is a 
soil borne phytopathogenic fungi cause different diseases 
in plants. Besides their pathogenicity these fungi also 
produce a wide range of secondary compound. The present 
study belongs to evaluate the anticancer potentials of of a 
new secondary metabolites isolated from S. rolfsii, their 
multidrug resistance (MDR), and molecular docking study.
Materials and Methods
Soil samples collection: Soil samples were collected 
from different localities of District Malakand, Khyber 
Pakhtunkhwa Pakistan. The soil samples were collected 
in sterilized bags and transferred to Laboratory.
Isolation and preservation of fungi: By serial dilution 
technique, samples were inoculated using different 
selective fungal media. The fungi were identified by 
morphologically and microscopically at plant pathology 
department Agricultural University Peshawar Pakistan. 
Different fungi were isolated such as Nigrospora, 
Verticillium and Aspergillus spp. S. rolfsii was selected 
for the present study.
Extraction of crude metabolites: By using already 
optimized growth condition, the fresh fungal strains were 
cultured for production of secondary metabolites. Czapek 
Yeast-extract Broth (CYB), were prepared and sterilized 
at 121oC for 20 min. 5 days old cultured were inoculated 
in each Erlenmeyer flask containing media. The flask was 
incubated, at 25oC at 150 rpm in shaking incubator. After 
incubation period, 40% HCl were added to each flask, 
which helps in separating components of media. After 
vigorously mixing, equal volume of EtOAc was added in 
each flask. Mycelial biomass was filtered using Cheese 
cloth. The process was repeated three times. Ethyl acetate 
portion were separated using separating funnel. Anhydrous 
sulphate Na2SO4 were added for dehydration of organics 
layer and then filtered. The EtOAc were filter using 
whatman filter paper. The extract were then concentrated 
at 45oC in rotary evaporator.
Fractionation
The crude EtOAc extract of S. rolfsii were suspended 
in Distilled water and partitioned with n-hexane. So the 
n-hexane soluble parts were recovered. Similarly, EtOAc 
soluble fractions were also separated.
Isolation and purification of new compound 
EtOAc fraction of 25 gm was subjected to column 
chromatography using silica gel. First, slurry were made 
by mixing 25 gm extract with small quantity of silica gel. 
Then silica were soaked in n-hexane and introduced in the 
column through funnel. After this the sample were loaded 
into the column over silica gel, the column was elated 
with n-hexane, ethyl acetate Isocratic systems or stepwise 
gradient eluents were employed, depending on the nature 
of the components and of their separation. The present 
compound was obtained at 9.0:1.0 of EtOAc: n-hexane 
in yellow like appearance. the purity of compound was 
confirmed by Thin layer chromatography and subjected 
to Nuclear Magnetic Resonance for its characterization.
Assay for reversal of MDR in mouse lymphoma cells
Two cell lines i.e. L5178 MDR and L5178Y were 
grown on special media known as McCoy`s 5A medium 
containing 10% heat-inactivated horse serum, also added 
L-glutamine and antibiotics. Adjustment of cells at a 
density of 2×106 mL re-suspended in serum-free McCoy`s 
5A medium were carried out and distributed in 0.5 mL 
aliquots into Eppendorf centrifuge tubes. The tested 
compound was added at 2 μg/ml final concentrations, 
and the samples were incubated for 10 minutes at room 
temperature. For positive control, Verapamil was used 
(Cornwell et al., 1987; Rauf et al., 2015; Rauf et al., 2016) 
in 10 µg/ml concentration. 
The L5178 MDR and L5178Y parent cell lines were 
grown in McCoy`s 5A medium containing 10% heat-
inactivated horse serum, was completed with L-glutamine 
and antibiotics. The cells were adjusted to a density 
of 2×106 mL re-suspended in serum-free McCoy`s 5A 
medium and distributed in 0.5 mL aliquots into Eppendorf 
centrifuge tubes. The tested compound was added at 2 μg/
ml final concentrations, and the samples were incubated 
for 10 minutes at room temperature. Verapamil was 
applied as positive control (Cornwell et al., 1987) in 10 
µg/ml concentration. In the next step, Indicator rhodamine 
123 10 µL (5.2 µM final concentration) was added to the 
samples and incubated for 20 min at 37ºC, twice washed 
and re-suspended in 0.5 mL PBS. Partec CyFlow flow 
cytometer (Münster, Germany) was used to measure of 
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fluorescence of the cell population. The tested compound 
was dissolved in DMSO, which was also used as solvent 
control. The percentage of mean fluorescence intensity 
was calculated for the treated MDR and parental cell lines 
as compared with the untreated cells. The activity ratio R 
was calculated via the following formula (Cornwell et al., 




Isolation of screlotiumol (1)
EtOAc fraction (25 gm) was subjected to normal phase 
column chromatography. The column was eluted with 
n-hexane: EtOAc (1:9) which afforded a yellow compound 
named screlotiumol. The structure was elucidated by 
advanced NMR analysis. 
Screlotiumol 1 was isolated as a yellow solid from 
ethyl acetate fraction of Screlotium rolfsii. 
Screlotiumol was identified as C12H1605 (M.p=133-
136oC) EI-MS spectrum. IR (KBr, Cm−1) showed 
absorption peaks at 3355-3650 for OH stretching, 2988 
CH saturated stretching, 1650 C=O stretching. 1H-NMR 
(400 MHz, MeOD) δH: 6.79 (H-2, s), 2.65, 1.99 (2H-4, m), 
2.30, 1.99 (H-5, m: 2H), 3.6, (H-6, m), 4.84 (H-8, s), 1.41, 
1.39 (H-11, m, 2H), 1.67, 1.66 (H-12, m, 2H), 4.20 (H-13, 
d, j=2.3) respectively. 13C NMR; (CDCl3, 150 MHz) δc: 
187.2 (C-1), 108.2 (C-2), 199.9 (C-3), 38.5 (C-4), 38.6 
(C-5), 66.9 (C-6), 88.5 (C-8), 136.6 (C-9), 162.2 (C-10), 
25.9 (C-11), 33.0 (C-12) and 100.9 (C-13) respectively. 
On the basis of the advanced spectral analysis, the 
chemical structure of a new compound 1 was identified 
as (13-(3,3-dihydroxypropyl)-1,6-dihydroxy-3,4-dihydro-
1H-isochromen-8(5H)-one (1). Furthermore the structure 
of compound 1 was confirmed by HBMC correlations.
Docking studies
X-ray crystallographic structure of P-glycoprotein (P-
gp) having PDB four letter code 4Q9L of resolution 3.80Å 
was retrieved from the protein data bank (PDB) (Berman 
et al., 2000). This crystallographic structure was subjected 
to the energy refinement by swiss PDB viewer v4.1.0 
program (Guex and Peitsch, 1997). The compound-1 and 
the Rhodamine123 structures were drawn through Chem 
sketch (Li et al., 2004) and Avogadro,s software (Hanwell 
et al., 2012). 
The docking of Compound-1 and standard 
Rhodamine123 were carried out through Autodock Vina 
(Trott and Olson, 2010) and i-GEMDOCKv 2.1 software’s 
(Hsu et al., 2011). The docking method was optimized 
by an already co-crystallized ligand of the P-gp receptor.
Furthermore, all the default parameters were used for 
both Autodock Vina and i-GEMDOCKv 2.1 software’s 
(Rauf et al., 2015a; Rauf et al., 2015b; Rauf et al., 
2015c). The docking analysis was carried out through 
LIGPLOT+ version v.1.4.5 (Wallace et al., 1995), PyMOL 
(DeLano, 2002) and Discovery studio visualizer softwares 
(Visualizer, 2005).
Results and Discussion
To evaluate the ABCB1 transporter modulating 
Table 1. Effects of Compound-1 on the Rhodamine123 Accumulation Assay in L5178 MDR Mouse Lymphoma Cell
Sample (final concentration) μg/ml FSC SSC Mean FAR Peak Ch
1 PAR - 2315 684 70.8 - 69.8
2 PAR - 2134 603 65.5 - 67.3
3 MDR - 2339 753 2.01 - 1.6
MDR MEAN - 2326 914 1.64 - 1.54
4 Verapamil 10 2329 711 21.9 13.35 27.4
8 1 2 1843 1137 10.34 14.07 16.41
18 DMSO 0.20% 2247 759 1.02 0.62 0.931
19 MDR - 2313 1076 1.27 - 1.49























Table 2. Docking Statistics of Compound-1 and the Standard Rhodamine123 Against Mice P-glycoprotein   
Compound-Name Autodock Vina i-GEM DOCKB. Affinity Total Energy VDW HBond Elec
Compound-1 -6.8 -76 -56 -20 0
Rhodamine123 -8.2 -87 -86 -1 0
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potential, the fluorescence activity ratio (FAR) value 
was used. In the flow cytometry, the value of SSC (side 
scatter count) and FSC (forward scatter count) were 
increased, which indicates that the compounds (1) had 
membrane effect and the granulation of cytoplasm was 
increased. The FAR values obtained by using compound 
1, indicating that compound 1 is very effective MDR 
modulator in a short time experiment. Verapamil, which is 
a calcium channel blocker and chemosensitizer, was used 
as a positive control. On MDR mouse lymphoma cells the 
compound 1 was screen in one 2 μg/ml concentration. 
The 1 was strong modulators of the efflux pump activity 
(FAR 10.22, 2 µg/ml) 
Computational docking analysis has vital role in 
the discovery of new drugs. It primarily predicted the 
inhibiting potency of new compounds against the drug 
target proteins. Our molecular docking studies revealed 
that the docking of compound-1 which can co-relate with 
the in-vitro results. The docking experiment of standard 
Rhodamine123 and compound-1 was carried out against 
the crystal structure of P-gp. The docking of compound-1 
(Table 2) revealed a similar result as indicated from 
the Figure 2. The interaction analysis of compound-1 
(Figure 3) shows two types of contacts. One is hydrogen 
bonding and another is hydrophobic contacts, if such 
type of interactions are present in the new compounds 
then it will shows a good mediating biological activities. 
There are a total of seven hydrogen bonding with binding 
site of compound-1, including them two hydrogen bond 
observed from the Asn717 with a distance of 3.00Å and 
2.95Å. The other five hydrogen observed from the residues 
Tyr303 (2.85Å), Ser762 (3.25Å), Gln834 (2.80Å), Phe979 
(2.75Å) and Gln986 (2.99Å). The hydrophobic contacts of 
compound-1 in the binding site of P-gp were also observed 
from the surrounding residues such as Phe299, Gln721, 
Phe766, Met982 and Ala983. 
Moreover, further detail study will be needed to 
explore the anticancer potential of compound-1 against 
the targeted receptor. The preliminary result obtained from 
this study will leads to the discovery of new therapeutic 
agent for the treatment of cancer. 
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